LIVINGCELL ApS: Financial statements 2019
CVR: 27205607
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
LIVINGCELL ApS (CVR 27205607) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 669,166 and a net result of DKK 516,146 compared with DKK 693,175 the year before. That is a decrease of 25.2% compared with the year before. Equity in the 2019 report amounted to DKK 649,163. The solvency ratio was 77.7%.
- Gross Profit
- DKK 669,166
- Profit/Loss
- DKK 516,146
- Equity
- DKK 649,163
- Total Assets
- DKK 835,769
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 669 t. | 516 t. | 649 t. | - |
| 2018 | - | 894 t. | 693 t. | 823 t. | - |
| 2017 | - | 972 t. | 759 t. | 960 t. | - |
| 2016 | - | 633 t. | 493 t. | 201 t. | - |
| 2015 | - | 199 t. | 153 t. | 158 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout LIVINGCELL ApS
LIVINGCELL ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2003. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Anders Bek-Pedersen. The board consists of Anders Bek-Pedersen (chair). The company is owned by BEK-PEDERSEN HOLDING ApS. The company has 0 employees (2004). In 2025, the company reported a gross profit of DKK -13,500 and a net result of DKK -6,542 compared with DKK -17,604 the year before. Equity in the 2025 report amounted to DKK 115,908.